ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,644, issued on Nov. 11, was assigned to SML BIOPHARM Co. LTD. (Gwangmyeong-si, South Korea).
"Pharmaceutical composition containing stabilized nucleic acid adjuvant" was invented by Jae Hwan Nam (Goyang-si, South Korea), Gyo Chang Keum (Seoul, South Korea), Hyo Jung Park (Seoul, South Korea), Eun Kyoung Bang (Seoul, South Korea) and Hae Li Ko (Bucheon-si, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a pharmaceutical composition comprising a nucleic acid molecule of an adjuvant, a metal complex stabilizing the nucleic acid molecule, and optionally an immunogen that may be a peptide or a protein, or a co...